Open the map

PfizerPFE

Big pharma · NYSE · USA

$27.82
Down 0.6% todayClose

Up 12.4% this year and +14.5% since June 26, ahead of the life science sector at +10.7%. Pfizer supplies 3 mapped companies and buys from 5.

Market cap
$157B
This year
+12.4%
1 year
+6.6%
P/E
36.3
P/S
2.5
P/B
1.8

Price vs the life science sector

since Jun 26PFELife science sector, equal weight
Pfizer (PFE) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. PFE: +14.5% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+5%+10%+15%+20%Jun 26AugSepOct 8PFE +14.5%Sector +10.7% Pfizer (PFE) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. PFE: +14.5% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%Jun 26AugSepOct 8PFE+14.5%Sector+10.7%

Supply chain

5 suppliers · 3 customers
SUPPLIERS →→ CUSTOMERSThermo Fisher Scientific (TMO)TMOThermo Fisher Scien…−1.5%West Pharmaceutical Services (WST)WSTWest Pharmaceutical…−0.9%Charles River Laboratories (CRL)CRLCharles River Labor…−0.8%IQVIA Holdings (IQV)IQVIQVIA Holdings+0.3%Agilent Technologies (A)AAgilent Technologies−0.5%Cardinal Health (CAH)CAHCardinal Health+2.9%McKesson (MCK)MCKMcKesson+2.2%Cencora (COR)CORCencora+1.3%PFEPfizer

Suppliers 5

Customers 3

Open the full chain →

About Pfizer

Vaccines are what most people associate with Pfizer. The portfolio is considerably broader: oncology is a large part of it, and internal medicine covers much of the rest.

Theme exposure

Big pharmaOncologyVaccines

Products

  • Vaccines
  • Oncology
  • Internal medicine

Competitors

Risks

  • Patent cliff
  • Declining covid revenue
  • Acquisition integration

Same segment: Big pharma

Large, diversified pharmaceutical groups with broad portfolios across therapeutic areas. Segment 2 of 8 in the Medicine, pharma & life science value chain.

Johnson & JohnsonJNJ−0.8%AbbVieABBV+0.4%Merck & Co.MRK−0.3%Bristol Myers SquibbBMY−0.2%ZoetisZTS+2.1%

Compare PFE

Side by side with the largest companies in the same segment.

PFE vs JNJPFE vs ABBVPFE vs MRKPFE vs BMYPFE vs ZTS

See where Pfizer sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →